Pipeline embolization device as a standalone curative approach for recurrent sigmoid sinus DAVF.

Interv NeuroradiolSep 23, 2024 (epub)
Case ReportNeurosurgeryOpen access

Vera Sharashidze, Charlotte Chung, Peter Kim Nelson et al.

✦ AI-curated · Sources linked

Case in brief

A 74-year-old man developed a recurrent sigmoid sinus dural arteriovenous fistula after meningioma resection. The fistula recurred with worsening symptoms despite transvenous and middle meningeal artery embolization. Sinus sacrifice and transarterial embolization were unsuitable because the dominant right sigmoid sinus was important for cerebral venous drainage. A reconstructive approach using a Pipeline embolization device construct occluded the fistula while preserving sinus function. Follow-up angiography showed stable occlusion and normalized intracranial venous drainage.

What made this case unusual

Flow diversion was used to treat the recurrent fistula while preserving a dominant sigmoid sinus whose role in venous drainage made conventional options unsuitable.

Diagnostic / clinical pearl

When a dAVF involves a sinus essential to cerebral venous drainage, assess whether a reconstructive strategy can occlude the fistula while maintaining sinus function.

Source

Published in Interv Neuroradiol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurosurgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.